MedPath

effect of antihypertensive combination therapy with either CCB or diuretics on irbesartan on hypertensive patient with metabolic syndrome:A randomised controlled trial

Not Applicable
Conditions
hypertensive patient with metabolic syndorome
Registration Number
JPRN-UMIN000003458
Lead Sponsor
Kanazawa Medical University Diabetes & Endocrinology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Hypersensitivity 2)Pregnant woman or possibility of pregnancy 3)Diuretic and CCB are administered 4)Steroid or the immunosuppressive agent is taken 5)Patient who judged that doctor in charge is improper

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
degree and accomplishment of a BP recommended goal
Secondary Outcome Measures
NameTimeMethod
clinical parameters fasting glucose levels HOMA-R TG HDL-C LDL-C u-albumin:creatinine ratio e-GFR ICAM-1
© Copyright 2025. All Rights Reserved by MedPath